NNVC NanoViricides Inc.: יחס שווי חברה להכנסות

לוגו של חברה ציבורית NanoViricides Corp (NNVC)

NanoViricides, Inc. (NNVC) generates revenue based on the commercialization of its nanotherapeutic platform against HIV, herpes, and influenza. The EV/Sales multiple reflects the market value relative to revenue, where the value 0.00 characterizes this level. The company is currently testing the safety of molecules for skin treatment using unique "nanotraps" that block virions and prevent their mutation.

nanoviricides.com (NNVC): שווי חברה להכנסות מ-23.11.2025 עד 20.11.2026

NNVC (NanoViricides): פילוחים אנליטיים ודוחות לפי אינדיקטורים

- ציטוטים נוכחיים ותחזית שווי ממוצעת:
הערכת שווי פונדמנטלית של החברה:NNVC (NanoViricides Inc.)
מוצר מקורי של nanoviricides.com

For NanoViricides, Inc. (NNVC), which is developing a diversified portfolio of nanopharmaceuticals against various viruses, the EV/Sales ratio serves as an indicator of the business's market value adjusted for net debt. This metric compares the total enterprise value to revenue, allowing investors to assess the asset's fundamental stability and rule out speculative overheating amid tight monetary policy.